Five scientists have been awarded a $3-million Breakthrough Prize for their pivotal roles in creating the weight-loss drugs Ozempic and Wegovy, originally intended for diabetes treatment. These drugs mimic the hormone GLP-1, which regulates blood sugar and reduces appetite. Among the honored researchers are Daniel Drucker, Joel Habener, Jens Juul Holst, Svetlana Mojsov, and Lotte Bjerre Knudsen, who notably stabilized the drug for effective use. The impact of these medications goes beyond science, as they truly improve patients' quality of life, evidenced by personal success stories of significant weight loss.
"This class of drugs truly saves lives, changes lives and brings joy back to people's lives," says Ziyad Al-Aly, reflecting on the impact of weight-loss medications like Ozempic and Wegovy.
"It's a tremendous honour to receive this prestigious award," says Drucker. "But the most amazing gratification is when someone comes to my office and says, I lost 40 pounds [18 kg] and I feel healthier."
Collection
[
|
...
]